T. Rowe Price Investment Management, Inc. - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,386
-39.5%
1,610,4960.0%0.02%
-36.0%
Q2 2023$37,026
-36.5%
1,610,496
-18.2%
0.02%
-40.5%
Q1 2023$58,318
+19.5%
1,968,175
+0.6%
0.04%
+13.5%
Q4 2022$48,822
-99.9%
1,955,977
-2.0%
0.04%
+5.7%
Q3 2022$43,465,0001,996,5290.04%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 5,858,262$81,429,84212.61%
Aquilo Capital Management, LLC 782,219$10,872,8449.85%
BVF INC/IL 4,739,004$65,872,1561.78%
Redmile Group, LLC 1,868,507$25,972,2471.24%
Artal Group S.A. 1,805,346$25,0941.08%
Deer Management Co. LLC 615,895$8,560,9411.04%
Avoro Capital Advisors LLC 3,855,000$53,584,5000.84%
Rock Springs Capital Management LP 1,504,351$20,910,4790.56%
AtonRa Partners 19,172$266,4910.56%
Baker Brothers Advisors 4,750,400$66,030,5600.38%
View complete list of KYMERA THERAPEUTICS INC shareholders